logo
Plus   Neg
Share
Email

Conatus Pharmaceuticals Posting Strong Gain In Afternoon Trading

Shares of Conatus Pharmaceuticals (CNAT) have shown a strong move to the upside on Friday, with the biotechnology company climbing by 7.9 percent. Conatus reached a nearly two-month intraday high earlier in the session.

The jump by Conatus comes after the company announced that its exclusive license with Novartis (NVS) for the global development and commercialization of emricasan has become effective upon the receipt of a $7 million payment.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Comcast Corp. on Thursday reported a 14 percent increase in profit for the first quarter from last year on a double-digit growth in revenues. Adjusted earnings per share for the quarter beat analysts' expectations, while revenues missed their estimates. Total customer relationships increased by 3.6 percent to 30.7 million in the quarter and include net additions of 300,000. French banking major Societe Generale's covered bond vehicle Societe Generale SFH has issued 100-million euros-covered bond as a security token on the Ethereum blockchain. In a statement, the lender said, "obligations de financement de l'habitat" or OFH Tokens, backed by covered bonds, have been rated Aaa / AAA by Moody's and Fitch and have been fully subscribed by the parent. Ford Motor Co. plans to invest $500 million in electric truck maker Rivian, the companies said Wednesday. They will also work together to develop an all-new battery electric vehicle for Ford using Rivian's skateboard platform. Ford's investment comes just months after Rivian revealed two new products, an all-electric pickup and SUV.
Follow RTT